2025
The 2025 Faculty are yet to be announced. Below, the 2024 Faculty list is available for review.
2024
University of Pennsylvania |
Faculty, UBC and UCSF, Vice President of Ethics, CommonSpirit Health (California Region)
|
TOBB University of Economics and Technology |
Roche Diagnostics
|
Hackensack Meridian School of Medicine
|
University of the Free State |
|
Good Clinical Practice Alliance – Europe (GCPA) |
University of Massachusettes, Boston |
Touro University
|
|
Ghaiath Hussein MBBS MSc PhD

Inmaculada de Melo-Martín PhD

Eve Herold

Jeanne F Loring

Jan Piasecki PhD

Adarsh Srivastava PGDISAD

James J. Hughes PhD

Jonathan Moreno PhD

P. Elif Ekmekci MD PhD

Anita Ho PhD MPH

Bryn Williams-Jones PhD
Talia Arawi PhD

Frederick Licciardi MD

Ilene Wilets PhD

Perihan Elif Ekmekci MD,PhD

Joseph Lowy, M.D.


Joyce Tsoka-Gwegweni PhD

Bryan Pilkington PhD

John Loike PhD

Jacob Appel MD JD MPH

Francis P. Crawley MA
Francis P. Crawley is the Executive Director of the Good Clinical Practice Alliance – Europe (GCPA) in Brussels, Belgium. He is the founder and Director of the Strategic Initiative for Developing Capacity in Ethical Review (SIDCER). He coordinates the GCPA-SIDCER European Fellowship in Research Ethics (EFRE) He is a philosopher specialised in ethical, legal, and regulatory issues in health research, having taught at several European, Asian, and Middle East universities. He is the past Secretary General, Ethics Officer, and Chairman of the Ethics Working Party at the European Forum for Good Clinical Practice.
He currently chairs the methodologies sub-group of the Real Word Data Working Group at the Faculty of Pharmaceutical Medicine, Royal Colleges of Physicians. He has acted as an author or expert for the leading international and European research ethics and GCP guidelines, as well as for several guidelines in Asia, Africa, the Americas, and Europe.
He was for 15 years the Chairman of the Ethical Review Committee of the International Network for Cancer Treatment and Research (INCTR); a member of the INCTR Tissues Committee; and a member of the Ethics Committee of the European Organization for Research & Treatment of Cancer; Consultant to the Peking University Institutional Review Board; and a member of the Steering Committee of the Chinese Ethics Committee of Registering Clinical Trials (ChECRCT). He has been a member of the joint EMVI-AMVTN Ethical Review Committee; a Permanent Liaison Officer to the International Bioethics Committee of UNESCO; and a Contact Officer for CIOMS. In 2006 he was Visiting Expert in research ethics at the Ministry of Health, Singapore.
He was the committee chairman of the WHO guidelines on ethics committees and data monitoring committees; and he was a member of the Scientific Advisory Committee for the World Health Organization’s International Clinical Trials Registry Platform (ICTRP). He also served for four years on the UNAIDS Ethical Review Committee. He is a co-founder and past Steering Committee Member of the Global Forum for Bioethics in Research; a past member of the Committee of Interested Parties of the Centre for the Management of Intellectual Property in Health Research & Development; a past member of the European Science Foundation’s Education Working Group, and a past member of the WHO GCP Handbook drafting committee. In addition, he is a member of the Ethics Working Group, European Academy of Paediatrics (UEMS-EAP); and an investigator in several European Commission projects, including ‘The Development of European Standards on Confidentiality and Privacy in Healthcare among Vulnerable Patient Populations’, ‘Ethical Function in Hospital Ethics Committees’, & ‘Ethical Considerations in Clinical Trial Collaboration with Developing Countries’, ‘European Network for Expertise for Rare Paediatric Neurological Disorders (nEUroped)’ and Relating Expectations and Needs to the Participation and Empowerment of Children in Clinical Trials (RESPECT). He is also a member of past Vice-Chairman of the Ethics Committee of the International Society for Medical Publication Professionals.
He was the Co-facilitator for the Ethics Roundtable at the Africa Centre for Health & Population Studies in South Africa where he taught a modular GCP course and where he was a member of a DSMB for an HIV vertical transmission study. He is also a member of several regional organizations for ethics in research in Central and Eastern Europe, Asia, Africa, and Latin America. He founded the AfroGuide Project: Developing Guidelines for Health Research in Africa, with the UN Economic Commission for Africa and the African Union. He serves on several editorial boards for international journals.
Michael L. Gross PhD

Ghaiath Hussein, MBBS, MSc, PhD

Ghaiath Hussein, MBBS, MSc, PhD Assistant professor in medical ethics and law, School of Medicine, Trinity College Dublin, University of Dublin, Ireland
Ghaiath is a medical doctor, bioethicist, and public health specialist. He holds a medical degree (MBBS), a master’s in bioethics from the University of Toronto (Canada), and a PhD in bioethics from the University of Birmingham (UK). He has worked in the fields of health research, health policy and field epidemiology with a focus on humanitarian settings.
His major area of expertise and contribution is in bioethics with a focus on research ethics, public health ethics and humanitarian ethics. He has been teaching bioethics-related topics and courses for undergraduate and postgraduate students, residents, healthcare providers, and public health practitioners since 2010. He has been also actively involved in ethics-related consultations, especially in developing countries with some major agencies, including the WHO, UNESCO, and EMPHNET. He also contributed to some national and international books and training manuals of bioethics with a focus on the ethical issues related to clinical practice, health research, and global health. Recent studies focus on Research Ethics in complex humanitarian emergencies and north-south global ethics dialogue. Dr Hussein is a member of the Ethics Review Board of Médecins Sans Frontières (MSF – ERB) since 2020 and a member of the Ukraine Clinical Research Support Initiative (UCRSI).
Michael R. Berman, MD, MBI

Brian Milkin JD

Brian J. Malkin
Associate General Counsel, Teva Pharmaceuticals Brian J. Malkin supports Research and Development (R&D), Regulatory Affairs (RA), Commercial, Quality, Quality Assurance, and other client groups by counseling on FDA regulatory law and strategy, including expedited development pathways, labeling and safety issues, and pre-and post-approval development challenges. He serves as a Center of Excellence in regulatory law, including the issues under the FDCA, PHSA, BPCIA, PREA, BPCA, the Hatch-Waxman Act, the Orphan Drug Act, the User Fee Act and other laws. He represents Teva in informal and formal dispute resolution and litigation and develop advocacy strategies, submissions, appeals, and correspondence. He sits on R&D project teams across therapeutic areas to advise on legal and regulatory issues and post-approval development for innovative and biosimilar pharmaceutical products. He developes and maintains relationships with health authorities, external facing organizations, trade associations, and pharmaceutical industry counterparts. He also provides training for RA, R&D, and commercial functions on FDA legal and regulatory issues.Jacob M. Appel MD, JD, MPH
